logo
Select company
Select metric
$ -18.9MConsolidated Income
VS
Market
29
Sector
56
Industry
70
History
-
$ 0.33Close
$ 0.21 - $ 14.01 52-Week Range
Ticker Information

Ticker

ASBP

Company Name

ASPIRE BIOPHARMA HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ASPIRE BIOPHARMA HOLDINGS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ASBP - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -18.9M
3/31/2025$ -17.53M
12/31/2024$ -1.31M
9/30/2024$ -3.76M
6/30/2024$ -3.29M
3/31/2024$ -875.46K
12/31/2023$ 4.46M
9/30/2023$ 6.85M
6/30/2023$ 7.99M
3/31/2023$ 6.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -25.48K.
  • Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average Cons. Inc. has been $ -1.4M.
  • The median Cons. Inc. for ASPIRE BIOPHARMA HOLDINGS INC during this period was $ -450.46K
  • ASPIRE BIOPHARMA HOLDINGS INC reached its highest Cons. Inc. over the past 5 years at $ 7.99M.
  • The lowest Cons. Inc. recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe $ -18.9M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ASBP - Consolidated Income, Last 5 years

$ -18.9M

Minimum

Jun 30, 2025

$ 7.99M

Maximum

Jun 30, 2023

$ -1.4M

Average

$ -450.46K

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M